Methods of treating pigs with
View Patent ↗Disclosed are methods of administering at least two Bacillus strains to a pig, such as female breeding stock, nursery pigs, or other pigs. The Bacillus strains inhibit Clostridium in litters borne to the pig. The Bacillus strains also are useful when administered to herds lacking symptoms of Clostridium infection. Administration of the Bacillus strains improves performance of female breeding stock and in piglets borne by the female breeding stock.
1. A method comprising:
(a) administering a first composition to a pig in an effective amount to inhibit Clostridium in the pig, wherein the first composition comprises at least two Bacillus strains selected from strains 22CP1 (ATCC PTA-6508), 3AP4 (ATCC PTA-6506), 15AP4 (ATCC PTA-6507), 2084 (NRRL B-50013), LSSAO1 (NRRL B-50104), and 27 (NRRL B-50105); and
(b) administering a second composition to the pig based on a change in Clostridium strains to which the pig is exposed, wherein the second composition comprises at least two Bacillus strains selected from the group consisting of strains 22CP1 (ATCC PTA-6508), 15AP4 (ATCC PTA-6507), 2084 (NRRL B-50013), 27 (NRRL B-50105), 3AP4 (ATCC PTA-6506), and LSSAO1 (NRRL B-50104), and further wherein the second composition comprises at least one Bacillus strain that differs from the Bacillus strains in the first composition.
2. The method of claim 1 , wherein the first composition comprises the Bacillus strains 3AP4 (ATCC PTA-6506) and LSSAO1 (NRRL B-50104).
3. The method of claim 1 , wherein the first composition comprises the Bacillus strains 15AP4 (ATCC PTA-6507) and LSSA01 (NRRL B-50104).
4. The method of claim 1 , wherein the first and second compositions are administered to female breeding stock.
5. The method of claim 1 , wherein the first and second compositions are administered during gestation of the pig.
6. The method of claim 5 , wherein a total microbial count of 3.75×10 5 CFU/g of feed/day is administered.
7. The method of claim 1 , wherein the first and second compositions are administered during lactation of the pig.
8. The method of claim 7 , wherein a total microbial count of 8.5×10 8 CFU/g of feed/day is administered.
9. The method of claim 1 , wherein administration of the first and second compositions inhibit Clostridium in litters borne to the pig.
10. The method of claim 9 , wherein the Clostridium is Clostridium perfringes.
11. The method of claim 9 , wherein the Clostridium is Clostridium difficile.
12. The method of claim 1 , wherein administration of the first and second compositions provides at least one of the following in litters borne to the pig relative to that in litters borne to pigs that have not been administered the first and second compositions: (A) lower average scour scores in the first week after birth, and (B) a decrease in the percentage of scouring litters.
13. The method of claim 1 , wherein the pig is in a herd lacking symptoms of Clostridium infection.
14. The method of claim 1 , wherein administration of the first and second compositions decreases clostridial load in the gastrointestinal tract of piglets borne by the pig relative to that in piglets borne to pigs that have not been administered the Bacillus strains.
15. The method of claim 1 , wherein the pig is in a unit of pigs that are subclinical for clostridial scours.
16. The method of claim 1 , wherein performance of at least one of the pig and piglets borne by the pig is improved during lactation relative to pigs and piglets that have not been administered the first and second compositions.
17. The method of claim 1 , wherein the first and second compositions are administered when the pig is at least one of a nursery pig and a feedlot pig.
18. The method of claim 1 , wherein the pig is a gestating pig.
19. The method of claim 1 , wherein the second composition comprises the Bacillus strains 3AP4 (ATCC PTA-6506) and LSSAO1 (NRRL B-50104).
20. The method of claim 1 , wherein the second composition comprises the Bacillus strains 15AP4 (ATCC PTA-6507) and LSSA01 (NRRL B-50104).